EBVaGC patients also display distinct immune characteristics, including changes in immune response genes, elevated PD-L1 expression in both cancer and immune cells, increased T and NK cell infiltration, heightened expression of immune checkpoint markers, and elevated levels of some anti-tumor immunity factors [79,80,81]. The gene discussed is CD274; the disease is cancer.